GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma (STAR CNS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05242146 |
|
Recruitment Status :
Active, not recruiting
First Posted : February 16, 2022
Last Update Posted : April 20, 2023
|
Sponsor:
GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
Information provided by (Responsible Party):
Gossamer Bio Inc. ( GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | October 2024 |
| Estimated Study Completion Date : | October 2024 |